Tech Investors

Parker Institute for Cancer Immunotherapy

Parker Institute for Cancer Immunotherapy is an investing entity that backs tech companies raising capital.

Venture Investor Overview

Contact Information

Background Information

Overview

The Parker Institute for Cancer Immunotherapy brings together the best scientists, clinicians and industry partners to build a smarter and more coordinated cancer immunotherapy research effort to save lives.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

9/6/2022

Transaction History

Our records indicate that Parker Institute for Cancer Immunotherapy invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Executive Officer

Jeffrey Bluestone

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Parker Institute for Cancer Immunotherapy has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Browse more tech investors:

Park Cities Asset Management | Partners Innovation Fund

Share this article

About Our Tech Company Investor Database

This tech investor profile is powered by VentureDeal.com, a leading supplier of tech investor funding data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary